XORTX Therapeutics Names Michael Bumby as CFO; U.S.-listed Shares Down 4%

MT Newswires2024/12/19 21:21

Correction: -- XORTX Therapeutics Brief: Naming Dr. Michael Bumby, a Biotech/pharma Industry Veteran, as Its Chief Financial Officer Replacing James Fairbairn

MT Newswires2024/12/19 20:20

XORTX Therapeutics Brief: Naming Dr. Michael Bumby, a Biotech/pharma Industry Veteran, as Its Chief Financial Officer Replacing James Fairbairn

MT Newswires2024/12/19 20:04

XORTX Strengthens Executive Team

GlobeNewswire2024/12/19 20:00

XORTX Announces Presentation at the Rare and Genetic Disease Summit

GlobeNewswire2024/12/12 22:17

XORTX Therapeutics Files to Sell 810,810 Common Shares for Holders

Seeking Alpha2024/11/16 06:10